ATE110267T1 - Verfahren zur hestellung von tabletten, die sprühgetrocknetes naproxen oder naproxen natriumsalz enthalten. - Google Patents

Verfahren zur hestellung von tabletten, die sprühgetrocknetes naproxen oder naproxen natriumsalz enthalten.

Info

Publication number
ATE110267T1
ATE110267T1 AT90314164T AT90314164T ATE110267T1 AT E110267 T1 ATE110267 T1 AT E110267T1 AT 90314164 T AT90314164 T AT 90314164T AT 90314164 T AT90314164 T AT 90314164T AT E110267 T1 ATE110267 T1 AT E110267T1
Authority
AT
Austria
Prior art keywords
tablets
naproxen
spray dried
manufacture
drug
Prior art date
Application number
AT90314164T
Other languages
English (en)
Inventor
Roy Kuramoto
Randal Owen Pendleton
Zadauddin Tanwir Chowhan
Hafez Hafezzadeh
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Application granted granted Critical
Publication of ATE110267T1 publication Critical patent/ATE110267T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90314164T 1989-12-22 1990-12-21 Verfahren zur hestellung von tabletten, die sprühgetrocknetes naproxen oder naproxen natriumsalz enthalten. ATE110267T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45510989A 1989-12-22 1989-12-22

Publications (1)

Publication Number Publication Date
ATE110267T1 true ATE110267T1 (de) 1994-09-15

Family

ID=23807439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90314164T ATE110267T1 (de) 1989-12-22 1990-12-21 Verfahren zur hestellung von tabletten, die sprühgetrocknetes naproxen oder naproxen natriumsalz enthalten.

Country Status (16)

Country Link
EP (1) EP0436373B1 (de)
JP (1) JPH05320045A (de)
KR (1) KR910011241A (de)
AT (1) ATE110267T1 (de)
AU (1) AU640725B2 (de)
CA (1) CA2032956A1 (de)
DE (1) DE69011836T2 (de)
ES (1) ES2063296T3 (de)
FI (1) FI906372L (de)
HU (1) HUT59594A (de)
IE (1) IE904666A1 (de)
IL (1) IL96749A0 (de)
NO (1) NO905557L (de)
NZ (1) NZ236631A (de)
PT (1) PT96229B (de)
ZA (1) ZA9010353B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI944855L (fi) * 1992-04-15 1994-10-14 Marion Merrell Dow Inc Aminoguanidiinin suihkukuivausmenetelmä
WO1998024410A2 (en) * 1996-12-03 1998-06-11 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
RU2191577C1 (ru) * 2001-04-19 2002-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая противовоспалительная композиция и способ ее получения
DE60225560T2 (de) * 2001-07-30 2009-04-02 Dsm Ip Assets B.V. Zusammensetzung enthaltend epigallocatechin-gallat
KR100664822B1 (ko) 2002-02-01 2007-01-04 화이자 프로덕츠 인코포레이티드 변형된 분무-건조 장치를 이용한 균질한 분무-건조된 고체비결정성 약물 분산액의 제조 방법
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
JP2008222567A (ja) * 2007-03-08 2008-09-25 Iwate Univ 微粒子の製造方法
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
US20190105274A1 (en) * 2015-07-13 2019-04-11 Kyowa Hakko Bio Co., Ltd. Tablets containing arginine at high concentration
JP6619644B2 (ja) * 2015-12-22 2019-12-11 アサヒグループ食品株式会社 錠剤の製造方法、及び錠剤原料用顆粒の製造方法
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
ES2977276T3 (es) * 2019-08-26 2024-08-21 Dsm Ip Assets Bv Forma de dosificación oral sólida que comprende naproxeno y vitamina B12

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3883098T2 (de) * 1987-07-08 1993-12-02 American Home Prod Sprühgetrocknete Ibuprofen-Zusammensetzungen.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.

Also Published As

Publication number Publication date
AU6837590A (en) 1991-06-27
PT96229B (pt) 1998-06-30
KR910011241A (ko) 1991-08-07
ES2063296T3 (es) 1995-01-01
AU640725B2 (en) 1993-09-02
FI906372A0 (fi) 1990-12-21
IL96749A0 (en) 1991-09-16
NO905557L (no) 1991-06-24
PT96229A (pt) 1991-09-30
DE69011836D1 (de) 1994-09-29
DE69011836T2 (de) 1995-03-09
EP0436373A1 (de) 1991-07-10
HU908395D0 (en) 1991-07-29
HUT59594A (en) 1992-06-29
EP0436373B1 (de) 1994-08-24
CA2032956A1 (en) 1991-06-23
FI906372A7 (fi) 1991-06-23
NZ236631A (en) 1993-03-26
NO905557D0 (no) 1990-12-21
ZA9010353B (en) 1992-08-26
JPH05320045A (ja) 1993-12-03
IE904666A1 (en) 1991-07-17
FI906372L (fi) 1991-06-23

Similar Documents

Publication Publication Date Title
DE69011836D1 (de) Verfahren zur Hestellung von Tabletten, die sprühgetrocknetes Naproxen oder Naproxen Natriumsalz enthalten.
ATE66141T1 (de) Pharmazeutische zusammensetzung.
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
KR880004805A (ko) 분무건조된 아세트아미노펜
BR9206996A (pt) Composição adequada para preparar esferóides por esferoidização processo para produzir um material em partículas processo para produzir uma forma de dosagem de sólido esferoidizado em partículas e forma de dosagem sólida
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
PT88557A (pt) Process for the production of pharmaceutical compositions for sustained and controlled release of drug comprising water-insoluble polypeptides
DE3780056D1 (de) Verfahren zur herstellung von arzneimittelformulierungen mit gesteuerter und verlaengerter wirkung in einzeldosisform mit einheitlichen und vergleichbaren bioverfuegbarkeitscharakteristika.
ATE66144T1 (de) Herstellungsverfahren fuer arzneimittel mit verzoegerter wirkstoffabgabe.
RU2002123182A (ru) Содержащая ибупрофен композиция
ATE60711T1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
RU93009815A (ru) Анальгезирующее жаропонижающее лекарственное средство и способ его получения
ATE17650T1 (de) Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
GB1296944A (de)
HUT48797A (en) Insecticides, acarycides and nematocides containing as active substance derivatives of aryl-pirrol and process for production of the active substances
GB1506345A (en) Multitioned tablets
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
ES2038587T3 (es) Procedimiento para el secado y granulado simultaneo de extractos de sangre desalbuminada de ternero, granulado obtenido segun este procedimiento y su utilizacion para la fabricacion de preparados farmaceuticos.
MY101266A (en) Pharmaceutical formulations
CZ286197B6 (cs) Příprava tablet kyseliny fusidové
RU2188019C1 (ru) Фармацевтическая композиция, обладающая противогрибковой активностью, и способ ее получения
JPS6026093B2 (ja) ゲフアルナート含有固型製剤の製造方法
RU97106462A (ru) Способ получения таблетированной формы препарата
UA13210A (uk) Спосіб одержаhhя твердої лікувальhої форми дігідропірідіhу а у вигляді порошку, граhул або таблеток
RU98115790A (ru) Способ получения таблеток ранитидина

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties